30/09, Startup Exhibition, Cluster „NextGen Health", ST75
Key Facts
Company Description
InhalPlus’ mission is to set a new standard in respiratory care with its patented, non-invasive inhalation technology. We ensure high-dose drug delivery in respiratory support, seamlessly integrated into existing workflows. Scalable to adults with COPD and asthma, our technology opens the door to significantly broader treatment opportunities.
Product/Service Description
We help preterm infants survive. Current treatment options are invasive or not effective. We offer the missing link: an inhalation-based therapy that overcomes the inefficiencies of current methods.
Website
https://inhalplus.com
Crunchbase
https://crunchbase.com/organization/inhalplus
Country
Germany
Founding Year
2024
Employees
< 5
Company Stage
MVP/Prototype
Business Model
B2B
Focus Industries
Active Markets
(5 most relevant ones)
Germany, Switzerland
Look for at Bits & Pretzels
Funding & Investors
3 Lead Investors
Capital Raised to Date
2 800 000 €
Last Funding Type
Other
Last Funding Date
April 2025
Capital Need (€)
< 5M
Currently Fundraising
(at the time of Bits & Pretzels 2025)
Yes
Growth Outlook
Traction
Received €1.5M EXIST and €1.3M IBT non-dilutive funding. PoC study with 40 preterm infants 2025–2026
Monetization Model
Subscription model for consumables, which require weekly replacement, ensuring recurring revenue.
3 Reference Customers
Hannover Medical School (MHH), University Medical Center Schleswig-Holstein (UKSH)